Greater Manchester Built Its Own NHS System Without Palantir

Greater Manchester just showed the entire UK that sometimes the best solution isn't the most expensive one.

While the rest of England's National Health Service rolled out a $400 million data platform from American software giant Palantir, this region of 3 million people stuck with something different. They built their own system over nearly a decade, and now claim it works better than the flashy alternative.

The stakes are real. For years, NHS patients have suffered because their medical records couldn't follow them between hospitals and clinics. Sometimes people died because critical information got lost in the shuffle between paper files, spreadsheets, and outdated computer systems.

Palantir's Federated Data Platform promised to fix this mess by creating one unified system across England. By early 2024, 139 of roughly 200 hospital trusts and 35 of 36 regional care boards had signed on.

But Greater Manchester's care board said no thanks. They'd already spent years developing their own Analytics and Data Science Platform, and they weren't about to abandon it.

The homegrown system does things Palantir's can't. It pulls in primary care data that the national platform doesn't access, and because local teams built it themselves, they can modify it faster when needs change.

At a May 2025 meeting, Greater Manchester's board concluded their platform exceeded what Palantir offers and runs two to three years ahead in some functions. Matt Hennessey, the region's chief data and analytics officer, put it bluntly: switching to Palantir "would be a retrograde step."

The Ripple Effect

Greater Manchester's success is fueling a national debate that matters far beyond one region. The UK government has until February 2026 to decide whether to terminate the Palantir contract early or let it run until 2031.

Politicians are asking a simple question: if one part of the country is thriving without this expensive American system, why does the rest need it? The answer could reshape how Britain's healthcare system handles patient data for years to come.

Other hospital trusts in Greater Manchester are reportedly using Palantir only minimally, despite appearing as active users in official statistics. They're watching to see if the locally developed alternative proves itself superior.

The broader implications extend beyond Britain. As European nations reconsider their dependence on American technology companies, Greater Manchester offers proof that homegrown solutions can compete with Silicon Valley's biggest names.

This isn't just about software or spreadsheets. It's about a region that believed in its own ability to solve problems, invested in building something that worked for their community, and refused to give up when everyone else went a different direction.

Sometimes the underdog story writes itself, and Greater Manchester is showing that local innovation can outperform corporate giants when the people building the tools actually understand the problems they're solving.